TLOG
Tetralogic Pharmaceuticals Corporation
An oncology-focused biopharmaceutical company that designed small-molecule drugs meant to coax cancer cells into dying on their own. Its lead drug, birinapant, mimics a natural protein to strip cancer cells of their ability to escape cell death, and the firm also worked on drugs to block harmful necrosis. The name 'TetraLogic' comes from its drug design being based on four amino acids — a tetrapeptide — copied from that natural protein. Founded in 2001 and based in Malvern, Pennsylvania.
CUSIP: 88165U109HealthcareUS1 holder
Total Value
$762.0K
Total Shares
325.6K
Net Share Change
+211.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
